These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29802070)

  • 1. BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy.
    Ryan KM; Dunne R; McLoughlin DM
    Brain Stimul; 2018; 11(5):1123-1131. PubMed ID: 29802070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.
    Maffioletti E; Gennarelli M; Gainelli G; Bocchio-Chiavetto L; Bortolomasi M; Minelli A
    J ECT; 2019 Sep; 35(3):189-194. PubMed ID: 30994478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
    Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
    Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients.
    Colle R; Trabado S; David DJ; Brailly-Tabard S; Hardy P; Falissard B; Fève B; Becquemont L; Verstuyft C; Corruble E
    Neuropsychobiology; 2017; 75(1):39-45. PubMed ID: 28848102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.
    Marano CM; Phatak P; Vemulapalli UR; Sasan A; Nalbandyan MR; Ramanujam S; Soekadar S; Demosthenous M; Regenold WT
    J Clin Psychiatry; 2007 Apr; 68(4):512-7. PubMed ID: 17474805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder.
    Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2016 May; 76():1-8. PubMed ID: 26859236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder.
    Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
    Brain Behav; 2018 Nov; 8(11):e01101. PubMed ID: 30273985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.
    Piccinni A; Del Debbio A; Medda P; Bianchi C; Roncaglia I; Veltri A; Zanello S; Massimetti E; Origlia N; Domenici L; Marazziti D; Dell'Osso L
    Eur Neuropsychopharmacol; 2009 May; 19(5):349-55. PubMed ID: 19223156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between dietary quality, serum brain-derived neurotrophic factor (BDNF) level, and the Val66met polymorphism in predicting depression.
    Froud A; Murphy J; Cribb L; Ng CH; Sarris J
    Nutr Neurosci; 2019 Jul; 22(7):513-521. PubMed ID: 29280414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only.
    Haghighi M; Salehi I; Erfani P; Jahangard L; Bajoghli H; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2013 Jul; 47(7):908-15. PubMed ID: 23583029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression.
    Caldieraro MA; McKee M; Leistner-Segal S; Vares EA; Kubaski F; Spanemberg L; Brusius-Facchin AC; Fleck MP; Mischoulon D
    World J Biol Psychiatry; 2018 Aug; 19(5):402-409. PubMed ID: 28656803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy.
    Kleimann A; Kotsiari A; Sperling W; Gröschl M; Heberlein A; Kahl KG; Hillemacher T; Bleich S; Kornhuber J; Frieling H
    J Neural Transm (Vienna); 2015 Jun; 122(6):925-8. PubMed ID: 25387785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-Derived Neurotrophic Factor in the Cerebrospinal Fluid Increases During Electroconvulsive Therapy in Patients With Depression: A Preliminary Report.
    Mindt S; Neumaier M; Hellweg R; Sartorius A; Kranaster L
    J ECT; 2020 Sep; 36(3):193-197. PubMed ID: 32118691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy.
    Bousman CA; Katalinic N; Martin DM; Smith DJ; Ingram A; Dowling N; Ng C; Loo CK
    J ECT; 2015 Jun; 31(2):129-35. PubMed ID: 25148110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.
    Bocchio-Chiavetto L; Zanardini R; Bortolomasi M; Abate M; Segala M; Giacopuzzi M; Riva MA; Marchina E; Pasqualetti P; Perez J; Gennarelli M
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):620-4. PubMed ID: 16757154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of electroconvulsive therapy on serum levels of brain-derived neurotrophic factor and nerve growth factor in treatment resistant major depression.
    Bilgen AE; Bozkurt Zincir S; Zincir S; Ozdemir B; Ak M; Aydemir E; Sener I
    Brain Res Bull; 2014 May; 104():82-7. PubMed ID: 24747833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOMA-IR increase after antidepressant treatment in depressed patients with the Met allele of the Val66Met BDNF genetic polymorphism.
    Martin S; Colle R; El Asmar K; Rigal A; Vievard A; Feve B; Becquemont L; Verstuyft C; Corruble E
    Psychol Med; 2019 Oct; 49(14):2364-2369. PubMed ID: 30526722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RETRACTED: Electroconvulsive therapy and aerobic exercise training increased BDNF and ameliorated depressive symptoms in patients suffering from treatment-resistant major depressive disorder.
    Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Kirov R; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2014 Oct; 57():117-24. PubMed ID: 25073431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Cognitive Outcomes After ECT Depending on BDNF and COMT Polymorphisms.
    Bennett DM; Currie J; Fernie G; Perrin JS; Reid IC
    J ECT; 2016 Dec; 32(4):243-250. PubMed ID: 27191122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.